000			01780 a2200517 4500
005			20250513171251.0
264		0	_c19990503
008			199905s 0 0 eng d
022			_a0390-6078
040			_aNLM _beng _cNLM
100	1		_aSan Miguel, J F
245	0	0	_aTreatment of multiple myeloma. _h[electronic resource]
260			_bHaematologica _cJan 1999
300			_a36-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnemia _xetiology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBone Marrow Purging
650	0	4	_aBone Marrow Transplantation _xmortality
650	0	4	_aContraindications
650	0	4	_aDiphosphonates _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xtherapeutic use
650	0	4	_aInfection Control
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aKidney Failure, Chronic _xetiology
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMultiple Myeloma _xcomplications
650	0	4	_aMyeloma Proteins _xanalysis
650	0	4	_aOsteolysis _xdrug therapy
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Autologous
650	0	4	_aTransplantation, Homologous
700	1		_aBladé Creixenti, J
700	1		_aGarcía-Sanz, R
773	0		_tHaematologica _gvol. 84 _gno. 1 _gp. 36-58
999			_c10051118 _d10051118